Government-Owned Inventions; Availability for Licensing, 14670 [2024-04060]

Download as PDF 14670 Federal Register / Vol. 89, No. 40 / Wednesday, February 28, 2024 / Notices Requests to participate as a speaker must include all of the following information: 1. The name and email address of the person desiring to participate 2. The organization(s) that person represents, if any 3. The document(s) and primary article(s) of interest, listed in order of the speaker’s priorities Other Information: Written comments should be emailed to oga.rsvp@hhs.gov with the subject line ‘‘Written Comment Re: Stakeholder Listening Session on public health emergencies preparedness and response negotiations’’ by Wednesday, April 17, 2024. We look forward to your comments on these matters. Dated: February 22, 2024. Susan Kim, Principal Deputy Assistant Secretary. [FR Doc. 2024–04080 Filed 2–27–24; 8:45 am] BILLING CODE 4150–38–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Government-Owned Inventions; Availability for Licensing AGENCY: National Institutes of Health, HHS. ACTION: Notice. The invention listed below is owned by an agency of the U.S. Government and is available for licensing to achieve expeditious commercialization of results of federally-funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing. FOR FURTHER INFORMATION CONTACT: Wade Green at (301) 761–7505 or greenww@nih.gov. Licensing information may be obtained by communicating with the Technology Transfer and Intellectual Property Office, National Institute of Allergy and Infectious Diseases, 5601 Fishers Lane, Rockville, MD 20852: tel. 301–496– 2644. A signed Confidential Disclosure Agreement will be required to receive copies of unpublished information related to the invention. SUPPLEMENTARY INFORMATION: Technology description follows: An Innovative Adapter for Expedited and Automated Thawing of viably Frozen Cells. ddrumheller on DSK120RN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 19:59 Feb 27, 2024 Jkt 262001 Description of Technology This technology is a device and system for expediting the thawing frozen specimens (e.g., cryopreserved cells) contained in cryo-vials, offering a breakthrough solution for researchers seeking efficiency and precision in their workflows. The device is equipped with a small elongated tubular adaptor that suspends a cryo-vial of frozen cells over a centrifuge tube containing culture medium in an inverted position. With a focus on speed, efficiency and automation, the adaptor dramatically expedites the process of recovering viable cells from frozen specimens. It reduces per-sample labor time for thawing from several minutes to a few seconds, enabling a single technician to simultaneously thaw multiple vials within the capacity of centrifuges. The cells, once thawed, are diluted instantly into growth medium contained in the centrifuge tubes and spend essentially no time in liquid cryopreservative. The automated mechanism ensures a precise and controlled thawing environment maintaining optimal temperature conditions throughout the thawing process. Potential Commercial Applications: • This device can be used in sample preparation and cell culturing. • Applicable for research materials, medical and non-medical devices and consumer products. Competitive Advantages: • Provides a faster process of recovering viable cells from frozen specimens. • Eliminates multi-step processes. • High throughput system with reduced variability. • Constant environment control. Development Stage: • Prototype Inventors: Dr. Mario Roederer, Dr. Pratip Chattopadhyay and Margaret Beddall, all of NIAID. Publications: n/a. Intellectual Property: HHS Reference No. E–080–2015–0–EIR–00 U.S. Patent Application No. 14/661,449, filed on March 18, 2015; Published Patent Application US20160274004A1 on September 22, 2016; U.S. Patent 9,663,812 issued May 30, 2017. Licensing Contact: To license this technology, please contact Wade Green at (301) 761–7505 or greenww@nih.gov. and reference E–080–2015. Collaborative Research Opportunity: The National Institute of Allergy and Infectious Diseases is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize this technology. For PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 collaboration opportunities, please contact Wade Green at (301) 761–7505 or greenww@nih.gov. Dated: February 7, 2024. Surekha Vathyam, Deputy Director, Technology Transfer and Intellectual Property Office, National Institute of Allergy and Infectious Diseases. [FR Doc. 2024–04060 Filed 2–27–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Environmental Health Sciences; Notice of Closed Meetings Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Environmental Health Sciences Special Emphasis Panel; Career Development in K Applications. Date: March 20–21, 2024. Time: 10:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Environmental Health Science, 530 Davis Drive, Keystone Building, Durham, NC 27713 (Virtual Meeting). Contact Person: Beverly W. Duncan, Ph.D., Scientific Review Officer, Division of Extramural Research and Training, National Institute of Environmental Health Science, Keystone Building, 530 Davis Drive, Room 3130, Durham, NC 27713, (240) 353–6598, beverly.duncan@nih.gov. Name of Committee: National Institute of Environmental Health Sciences Special Emphasis Panel; Exposome Research Coordination to Accelerate Precision Environmental Health (PEH). Date: April 3, 2024. Time: 10:30 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Environmental Health Science, 530 Davis Drive, Keystone Building, Durham, NC 27713 (Virtual Meeting). Contact Person: Leroy Worth, Ph.D., Scientific Review Officer, Scientific Review E:\FR\FM\28FEN1.SGM 28FEN1

Agencies

[Federal Register Volume 89, Number 40 (Wednesday, February 28, 2024)]
[Notices]
[Page 14670]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-04060]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Government-Owned Inventions; Availability for Licensing

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The invention listed below is owned by an agency of the U.S. 
Government and is available for licensing to achieve expeditious 
commercialization of results of federally-funded research and 
development. Foreign patent applications are filed on selected 
inventions to extend market coverage for companies and may also be 
available for licensing.

FOR FURTHER INFORMATION CONTACT: Wade Green at (301) 761-7505 or 
[email protected]. Licensing information may be obtained by communicating 
with the Technology Transfer and Intellectual Property Office, National 
Institute of Allergy and Infectious Diseases, 5601 Fishers Lane, 
Rockville, MD 20852: tel. 301-496-2644. A signed Confidential 
Disclosure Agreement will be required to receive copies of unpublished 
information related to the invention.

SUPPLEMENTARY INFORMATION: Technology description follows:
    An Innovative Adapter for Expedited and Automated Thawing of viably 
Frozen Cells.

Description of Technology

    This technology is a device and system for expediting the thawing 
frozen specimens (e.g., cryopreserved cells) contained in cryo-vials, 
offering a breakthrough solution for researchers seeking efficiency and 
precision in their workflows. The device is equipped with a small 
elongated tubular adaptor that suspends a cryo-vial of frozen cells 
over a centrifuge tube containing culture medium in an inverted 
position. With a focus on speed, efficiency and automation, the adaptor 
dramatically expedites the process of recovering viable cells from 
frozen specimens. It reduces per-sample labor time for thawing from 
several minutes to a few seconds, enabling a single technician to 
simultaneously thaw multiple vials within the capacity of centrifuges. 
The cells, once thawed, are diluted instantly into growth medium 
contained in the centrifuge tubes and spend essentially no time in 
liquid cryopreservative.
    The automated mechanism ensures a precise and controlled thawing 
environment maintaining optimal temperature conditions throughout the 
thawing process.
    Potential Commercial Applications:
     This device can be used in sample preparation and cell 
culturing.
     Applicable for research materials, medical and non-medical 
devices and consumer products.
    Competitive Advantages:
     Provides a faster process of recovering viable cells from 
frozen specimens.
     Eliminates multi-step processes.
     High throughput system with reduced variability.
     Constant environment control.
    Development Stage:
     Prototype
    Inventors: Dr. Mario Roederer, Dr. Pratip Chattopadhyay and 
Margaret Beddall, all of NIAID.
    Publications: n/a.
    Intellectual Property: HHS Reference No. E-080-2015-0-EIR-00 U.S. 
Patent Application No. 14/661,449, filed on March 18, 2015; Published 
Patent Application US20160274004A1 on September 22, 2016; U.S. Patent 
9,663,812 issued May 30, 2017.
    Licensing Contact: To license this technology, please contact Wade 
Green at (301) 761-7505 or [email protected]. and reference E-080-2015.
    Collaborative Research Opportunity: The National Institute of 
Allergy and Infectious Diseases is seeking statements of capability or 
interest from parties interested in collaborative research to further 
develop, evaluate, or commercialize this technology. For collaboration 
opportunities, please contact Wade Green at (301) 761-7505 or 
[email protected].

    Dated: February 7, 2024.
Surekha Vathyam,
Deputy Director, Technology Transfer and Intellectual Property Office, 
National Institute of Allergy and Infectious Diseases.
[FR Doc. 2024-04060 Filed 2-27-24; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.